Epizyme, Inc.

MORGAN STANLEY

Report date

6/30/2022

Quarter

2022 Q2

Filed

10/27/2022

Shares

836,955

Value ($000)

1,229

Weight

0.0%

2013 Q4 - 2022 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	10/27/2022	1,229	0.0%	836,955	6/30/2022
2022 Q1	10/27/2022	941	0.0%	818,391	3/31/2022
2021 Q4	2/14/2022	1,970	0.0%	788,360	12/31/2021
2021 Q3	11/15/2021	13,867	0.0%	2,708,473	9/30/2021
2021 Q2	8/23/2021	16,817	0.0%	2,023,752	6/30/2021
2021 Q1	5/17/2021	16,367	0.0%	1,879,041	3/31/2021
2020 Q4	2/16/2021	20,300	0.0%	1,869,246	12/31/2020
2020 Q3	11/13/2020	17,291	0.0%	1,449,327	9/30/2020
2020 Q2	8/14/2020	11,026	0.0%	686,569	6/30/2020
2020 Q1	5/26/2020	1,422	0.0%	91,695	3/31/2020
2019 Q4	2/14/2020	9,511	0.0%	386,637	12/31/2019
2014 Q1	5/13/2014	355	0.0%	15,588	3/31/2014
2013 Q4	2/13/2014	349	0.0%	16,802	12/31/2013